Tamoxifen breast cancer treatment

Tamoxifen is tamoxifen breast cancer treatment of the most common endocrine therapy drugs. It has tamoxifen breast cancer treatment shown to decrease the chance of recurrence in some early-stage breast cancers and to prevent the development of cancer in the opposite breast. Tamoxifen can also slow or stop the growth of cancer cells present in the body. There are an estimated 29 million women at increased risk for breast cancer in this country, and tamoxifen may offer another alternative to watchful waiting or prophylactic preventative mastectomy. Tamoxifen is classified as a selective estrogen receptor modulator SERM and works as an anti-estrogen: